Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) ...
Although rituximab (R) is commonly used for patients with advanced follicular lymphoma (FL) requiring treatment, the optimal associated chemotherapy regimen has yet to be clarified. The April 20, 2013 ...
Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results